Dr. Xuemei Cai is a board‑certified neurologist and neurointensivist with recognized expertise at the intersection of acute neurologic care, digital medicine, and translational clinical research. She serves as an Attending Neurointensivist at Tufts Medical Center and as Senior Medical Director and Global Development Lead at Pfizer Research & Development, She is internationally recognized for her work in neurocritical care, stroke, intracerebral hemorrhage, wearable and digital biomarkers, and patient‑centric clinical trial design.
KEY INTERESTS AND RESEARCH HIGHLIGHTS
- Investigator or co‑investigator on numerous NIH‑, industry‑, and foundation‑funded multicenter trials spanning stroke, intracerebral hemorrhage, traumatic brain injury, epilepsy, neuroprotection, and critical care therapeutics.
- Key contributor to large‑scale studies validating wearables, accelerometry, gait analysis, circadian rhythm, and remote functional assessments, published in JAMA Network Open, npj Digital Medicine, Scientific Reports, Sensors, and related journals.
- Co‑author of institutional and peer‑reviewed clinical guidelines and book chapters
